ProfileGDS4718 / 210442_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 46% 48% 52% 48% 51% 50% 49% 50% 50% 46% 47% 51% 49% 51% 44% 46% 49% 47% 48% 51% 49% 46% 45% 49% 52% 46% 48% 44% 56% 51% 48% 57% 47% 47% 47% 50% 49% 52% 50% 49% 51% 48% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4817349
GSM549102patient 115, normal, homogenized [OPG study]5.3181446
GSM549104patient 119, normal, homogenized [OPG study]5.3997148
GSM549108patient 138, normal, homogenized [OPG study]5.6831652
GSM549119patient 077, normal, homogenized [OPG study]5.4019348
GSM549133patient 032, cancer, homogenized [OPG study]5.5325851
GSM549139patient 042, cancer, homogenized [OPG study]5.4870250
GSM549099patient 107, normal, homogenized [OPG study]5.4481449
GSM549109patient 139, normal, homogenized [OPG study]5.5312750
GSM549110patient 046, normal, homogenized [OPG study]5.5301650
GSM549114patient 063, normal, homogenized [OPG study]5.2721746
GSM549122patient 082, normal, homogenized [OPG study]5.3339547
GSM549134patient 033, cancer, homogenized [OPG study]5.554451
GSM549136patient 036, cancer, homogenized [OPG study]5.4247149
GSM549140patient 044, cancer, homogenized [OPG study]5.5199651
GSM549111patient 047, normal, homogenized [OPG study]5.176744
GSM549113patient 057, normal, homogenized [OPG study]5.2328546
GSM549132patient 031, cancer, homogenized [OPG study]5.4492949
GSM549137patient 038, cancer, homogenized [OPG study]5.3336347
GSM549142patient 047, cancer, homogenized [OPG study]5.5401548
GSM549100patient 110, normal, homogenized [OPG study]5.5659351
GSM549107patient 135, normal, homogenized [OPG study]5.4490349
GSM549115patient 068, normal, homogenized [OPG study]5.2136246
GSM549116patient 072, normal, homogenized [OPG study]5.2011145
GSM549120patient 078, normal, homogenized [OPG study]5.4465249
GSM549131patient 030, cancer, homogenized [OPG study]5.5944652
GSM549118patient 074, normal, homogenized [OPG study]5.3022746
GSM549129patient 027, cancer, homogenized [OPG study]5.4177448
GSM549123patient 088, normal, homogenized [OPG study]5.185844
GSM549124patient 006, cancer, homogenized [OPG study]5.8975156
GSM549126patient 015, cancer, homogenized [OPG study]5.5249251
GSM549128patient 025, cancer, homogenized [OPG study]5.4100448
GSM549103patient 117, normal, homogenized [OPG study]5.9281857
GSM549117patient 073, normal, homogenized [OPG study]5.3263647
GSM549138patient 041, cancer, homogenized [OPG study]5.3129647
GSM549141patient 045, cancer, homogenized [OPG study]5.3033947
GSM549130patient 028, cancer, homogenized [OPG study]5.4874850
GSM549101patient 111, normal, homogenized [OPG study]5.507649
GSM549105patient 128, normal, homogenized [OPG study]5.6474252
GSM549106patient 134, normal, homogenized [OPG study]5.4456150
GSM549112patient 048, normal, homogenized [OPG study]5.4495449
GSM549125patient 011, cancer, homogenized [OPG study]5.5991251
GSM549127patient 024, cancer, homogenized [OPG study]5.4036448
GSM549135patient 035, cancer, homogenized [OPG study]5.4505549